Lista de obras - Stefanie Hennig - Dominio Público Uruguay

A Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data

artículo científico publicado en 2016

A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing

artículo científico

A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients

artículo científico publicado en 2006

A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis

artículo científico publicado en 2006

A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis

artículo científico publicado en 2016

A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma

artículo científico publicado en 2015

An evaluation of the user-friendliness of Bayesian forecasting programs in a clinical setting

scientific article published on 06 August 2019

Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia.

artículo científico publicado en 2017

Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin

artículo científico publicado en 2011

Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.

artículo científico publicado en 2016

Balancing Antibacterial Efficacy and Reduction in Renal Function to Optimise Initial Gentamicin Dosing in Paediatric Oncology Patients

artículo científico publicado en 2017

Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis - an update

artículo científico publicado en 2017

Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.

scientific article published on 29 August 2016

CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision

artículo científico publicado en 2021

Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?

artículo científico publicado en 2017

Comment on "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials"

artículo científico publicado en 2018

Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis

artículo científico publicado en 2015

Comparison of Dose-Finding Designs for Narrow-Therapeutic-Index Drugs: Concentration-Controlled vs. Dose-Controlled Trials

artículo científico publicado en 2009

Comparison of methods to estimate glomerular filtration rate in paediatric oncology patients

artículo científico publicado en 2017

Concordance between criteria for covariate model building

artículo científico publicado en 2014

Differences in the Pharmacokinetics of Gentamicin between Oncology and Nononcology Pediatric Patients

artículo científico publicado en 2020

Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.

artículo científico publicado en 2015

Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

artículo científico publicado en 2017

Ethically Attractive Dose-Finding Designs for Drugs With a Narrow Therapeutic Index

artículo científico publicado en 2011

Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis.

artículo científico publicado en 2017

Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management

artículo científico publicado en 2015

Gentamicin Pharmacokinetics and Monitoring in Pediatric Febrile Neutropenic Patients

artículo científico publicado en 2016

Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.

artículo científico publicado en 2016

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

artículo científico publicado en 2014

Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI): a short report

artículo científico publicado en 2005

Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?

artículo científico publicado en 2019

Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients

artículo científico publicado en 2005

Optimizing disease progression study designs for drug effect discrimination.

artículo científico publicado en 2013

Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New Zealand

artículo científico publicado en 2019

Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?

artículo científico publicado en 2013

PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool.

artículo científico publicado en 2012

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review

artículo científico publicado en 2020

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

scientific article published on 01 January 2006

Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.

artículo científico publicado en 2017

Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs

artículo científico publicado en 2016

Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

artículo científico publicado en 2017

Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.

artículo científico publicado en 2017

Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus-infected children in relation to treatment outcomes

artículo científico publicado en 2019

Population pharmacokinetics of phenytoin in critically ill children.

artículo científico publicado en 2014

Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose

artículo científico publicado en 2014

Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis

artículo científico publicado en 2013

Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.

artículo científico publicado en 2017

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

scientific article published on 15 June 2019

Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection

artículo científico publicado en 2015

Quizzing for success: Evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses

artículo científico publicado en 2019

Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis

artículo científico publicado en 2014

Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection

artículo científico publicado en 2019

Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose

artículo científico publicado en 2015

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study

artículo científico publicado en 2007

The influence of underlying assumptions on evaluating the relative merits of concentration-controlled and dose-controlled trials

artículo científico publicado en 2009

To cap or not to cap: chemotherapy dosing in obese adult hematology patients

artículo científico publicado en 2014

Trial Treatment Length Optimization With an Emphasis on Disease Progression Studies

artículo científico publicado en 2009

and progression of lung disease in children with cystic fibrosis

artículo científico publicado en 2018

Lista de obras de Stefanie Hennig

A Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data

A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing

A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients

A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis

A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis

A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma

An evaluation of the user-friendliness of Bayesian forecasting programs in a clinical setting

Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia.

Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin

Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.

Balancing Antibacterial Efficacy and Reduction in Renal Function to Optimise Initial Gentamicin Dosing in Paediatric Oncology Patients

Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis - an update

Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.

CPT: Pharmacometrics &amp; Systems Pharmacology – Inception, Maturation, and Future Vision

Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?

Comment on "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials"

Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis

Comparison of Dose-Finding Designs for Narrow-Therapeutic-Index Drugs: Concentration-Controlled vs. Dose-Controlled Trials

Comparison of methods to estimate glomerular filtration rate in paediatric oncology patients

Concordance between criteria for covariate model building

Differences in the Pharmacokinetics of Gentamicin between Oncology and Nononcology Pediatric Patients

Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.

Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

Ethically Attractive Dose-Finding Designs for Drugs With a Narrow Therapeutic Index

Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis.

Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management

Gentamicin Pharmacokinetics and Monitoring in Pediatric Febrile Neutropenic Patients

Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI): a short report

Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?

Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients

Optimizing disease progression study designs for drug effect discrimination.

Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New Zealand

Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?

PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool.

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.

Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs

Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.

Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus-infected children in relation to treatment outcomes

Population pharmacokinetics of phenytoin in critically ill children.

Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose

Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis

Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection

Quizzing for success: Evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses

Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis

Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection

Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study

The influence of underlying assumptions on evaluating the relative merits of concentration-controlled and dose-controlled trials

To cap or not to cap: chemotherapy dosing in obese adult hematology patients

Trial Treatment Length Optimization With an Emphasis on Disease Progression Studies

and progression of lung disease in children with cystic fibrosis

CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision